本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

BridgeBio Pharma, Inc.

34.17
-0.6800-1.95%
盤後34.13-0.0379-0.11%19:57 EDT
成交量:178.91萬
成交額:6,189.43萬
市值:64.88億
市盈率:-9.67
高:35.60
開:35.43
低:34.15
收:34.85
資料載入中...
2019/06/27

持股變動聲明

Initial statement of beneficial ownership of securities
2019/06/27

持股變動聲明

Initial statement of beneficial ownership of securities
2019/06/27

持股變動聲明

Initial statement of beneficial ownership of securities
2019/06/26

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2019/06/25

SEC問詢函

[Cover]Correspondence
2019/06/24

SEC問詢函

[Cover]Correspondence
2019/06/24

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2019/06/17

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2019/06/11

[修訂]招股説明書

[Amend] General form for registration of securities under the Securities Act of 1933
2019/05/30

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/05/29

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/05/24

招股説明書

General form for registration of securities under the Securities Act of 1933
2018/12/13

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2018/12/12

持股變動聲明

Statement of changes in beneficial ownership of securities
2018/12/11

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2018/12/10

持股變動聲明

Statement of changes in beneficial ownership of securities
2018/12/07

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2018/12/06

持股變動聲明

Statement of changes in beneficial ownership of securities
2018/08/01

超過5%披露

General statement of acquisition of beneficial ownership